{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:41:46Z","timestamp":1761561706400},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T00:00:00Z","timestamp":1352419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s40261-012-0027-z","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T23:08:37Z","timestamp":1355958517000},"page":"835-842","source":"Crossref","is-referenced-by-count":4,"title":["Medical Service Encounters and Payments Associated with Topical Adjunctive Therapy Use of Timolol for Glaucoma"],"prefix":"10.1007","volume":"32","author":[{"given":"Jordana K.","family":"Schmier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Covert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,9]]},"reference":[{"issue":"3","key":"27_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"27_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2471\/BLT.07.041210","volume":"86","author":"S Resnikoff","year":"2008","unstructured":"Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ. 2008;86(1):63\u201370.","journal-title":"Bull World Health Organ"},{"key":"27_CR3","unstructured":"American Academy of Ophthalmology. Preferred practice pattern. In: Primary open-angle glaucoma. Limited revision. San Francisco: American Academy of Ophthalmology; 2003."},{"issue":"2","key":"27_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1167\/iovs.04-0729","volume":"46","author":"P Duggal","year":"2005","unstructured":"Duggal P, Klein AP, Lee KE, Iyengar SK, Klein R, Bailey-Wilson JE, et al. A genetic contribution to intraocular pressure: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 2005;46(2):555\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"27_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","volume":"114","author":"B Bengtsson","year":"2007","unstructured":"Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(2):205\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"27_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","volume":"114","author":"S Miglior","year":"2007","unstructured":"Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114(1):3\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"27_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ophtha.2004.10.034","volume":"112","author":"T Krupin","year":"2005","unstructured":"Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Ophthalmology. 2005;112(3):376\u201385.","journal-title":"Ophthalmology"},{"key":"27_CR8","unstructured":"IMS Global Track 2009."},{"key":"27_CR9","doi-asserted-by":"crossref","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u201313 (discussion 829\u201330).","DOI":"10.1001\/archopht.120.6.701"},{"key":"27_CR10","unstructured":"American Academy of Ophthalmology. Preferred practice pattern. In: Primary open angle glaucoma. San Francisco: American Academy of Ophthalmology; 2010."},{"key":"27_CR11","unstructured":"American Optometric Association. Optometric clinical practice guideline. In: Care of the patient with open angle glaucoma. St. Louis: American Optometric Association; 2010."},{"key":"27_CR12","unstructured":"National Institute for Health and Clinical Excellence. Glaucoma. In: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. London: National Institute for Health and Clinical Excellence; 2009."},{"issue":"6","key":"27_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0008-4182(03)80025-X","volume":"38","author":"M Houde","year":"2003","unstructured":"Houde M, Castilloux AM, Tingey D, Assalian A, LeLorier J. Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers. Can J Ophthalmol. 2003;38(6):469\u201375.","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"27_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00044011-200626090-00002","volume":"26","author":"S Vinker","year":"2006","unstructured":"Vinker S, Kaiserman I, Waitman DA, Blackman S, Kitai E. Prescription of ocular beta-blockers in patients with obstructive pulmonary disease: does a central electronic medical record make a difference? Clin Drug Investig. 2006;26(9):495\u2013500.","journal-title":"Clin Drug Investig"},{"key":"27_CR15","doi-asserted-by":"crossref","unstructured":"Valuck RJ, Perlman JI, Anderson C, Wortman GI. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers. Pharmacoepidemiol Drug Saf. 2001;10(6):511\u20136.","DOI":"10.1002\/pds.634"},{"issue":"1","key":"27_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00002018-200528010-00005","volume":"28","author":"YF Chen","year":"2005","unstructured":"Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous\/contraindicated drug combinations in general practice. Drug Saf. 2005;28(1):67\u201380.","journal-title":"Drug Saf"},{"key":"27_CR17","unstructured":"MAG Mutual Healthcare Solutions I. ICD-9-CM Volumes 1 & 2 for Physicians\u2019 Expert Edition. Atlanta: MAG Mutual Healthcare Solutions, Inc.; 2012."},{"key":"27_CR18","doi-asserted-by":"crossref","unstructured":"Kaiserman I, Fendyur A, Vinker S. Topical beta blockers in asthmatic patients-is it safe? Curr Eye Res. 2009;34(7):517\u201322.","DOI":"10.1080\/02713680902989337"},{"key":"27_CR19","doi-asserted-by":"crossref","unstructured":"Frishman WH, Kowalski M, Nagnur S, Warshafsky S, Sica D. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade. Heart Dis. 2001;3(6):386\u201397.","DOI":"10.1097\/00132580-200111000-00007"},{"key":"27_CR20","doi-asserted-by":"crossref","unstructured":"Han JA, Frishman WH, Wu Sun S, Palmiero PM, Petrillo R. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension. Cardiol Rev. 2008;16(2):95\u2013108.","DOI":"10.1097\/CRD.0b013e318156ec64"},{"issue":"6","key":"27_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ageing\/25.6.424","volume":"25","author":"P Diggory","year":"1996","unstructured":"Diggory P, Cassels-Brown A, Fernandez C. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. Age Ageing. 1996;25(6):424\u20138.","journal-title":"Age Ageing"},{"key":"27_CR22","doi-asserted-by":"crossref","unstructured":"Diggory P, Heyworth P, Chau G, McKenzie S, Sharma A. Unsuspected bronchospasm in association with topical timolol\u2014a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement? Age Ageing. 1994;23(1):17\u201321.","DOI":"10.1093\/ageing\/23.1.17"},{"issue":"Pt 5","key":"27_CR23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/eye.1993.151","volume":"7","author":"P Diggory","year":"1993","unstructured":"Diggory P, Heyworth P, Chau G, McKenzie S, Sharma A, Luke I. Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients. Eye (Lond). 1993;7(Pt 5):661\u20133.","journal-title":"Eye (Lond)"},{"issue":"1","key":"27_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archopht.123.1.35","volume":"123","author":"SA Gandolfi","year":"2005","unstructured":"Gandolfi SA, Chetta A, Cimino L, Mora P, Sangermani C, Tardini MG. Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers. Arch Ophthalmol. 2005;123(1):35\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"27_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ophtha.2006.02.062","volume":"113","author":"AJ Lee","year":"2006","unstructured":"Lee AJ, Wang JJ, Kifley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology. 2006;113(7):1069\u201376.","journal-title":"Ophthalmology"},{"issue":"9","key":"27_CR26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-009-1092-8","volume":"247","author":"WD Ramdas","year":"2009","unstructured":"Ramdas WD, van der Velde N, van der Cammen TJ, Wolfs RC. Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users. Graefes Arch Clin Exp Ophthalmol. 2009;247(9):1235\u201341.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"27_CR27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00417-006-0328-0","volume":"244","author":"H Uusitalo","year":"2006","unstructured":"Uusitalo H, Kahonen M, Ropo A, Maenpaa J, Bjarnhall G, Hedenstrom H, et al. Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1491\u20136.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"27_CR28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.18553\/jmcp.2009.15.7.568","volume":"15","author":"CL Gray","year":"2009","unstructured":"Gray CL, Gardner C. Adverse drug events in the elderly: an ongoing problem. J Manag Care Pharm. 2009;15(7):568\u201371.","journal-title":"J Manag Care Pharm"},{"key":"27_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/bmb\/ldm016","volume":"83","author":"KM Cresswell","year":"2007","unstructured":"Cresswell KM, Fernando B, McKinstry B, Sheikh A. Adverse drug events in the elderly. Br Med Bull. 2007;83:259\u201374.","journal-title":"Br Med Bull"},{"issue":"7","key":"27_CR30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/archophthalmol.2011.163","volume":"129","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Lee BW, Duncan M, Kao A, Huang JY, Singh K, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129(7):872\u20138.","journal-title":"Arch Ophthalmol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-012-0027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-012-0027-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-012-0027-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T22:39:39Z","timestamp":1643927979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-012-0027-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,9]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s40261-012-0027-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,9]]}}}